Overview

Treatment of Hidradenitis Suppurativa Using Etanercept

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Therapy with etanercept, a TNF inhibitor will reverse the inflammation, symptoms and quality of life and allow healing of HS.
Details
Lead Sponsor:
Penn State University
Collaborator:
Amgen
Treatments:
Etanercept